The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy
PHASE4CompletedINTERVENTIONAL
Enrollment
240
Participants
Timeline
Start Date
September 8, 2016
Primary Completion Date
September 29, 2017
Study Completion Date
September 30, 2017
Conditions
Breastcancer
Interventions
DRUG
PEG-rhG-CSF
Trial Locations (1)
100142
Peking University Cancer Hospital, Beijing
All Listed Sponsors
lead
Peking University
OTHER
NCT02944604 - The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy | Biotech Hunter | Biotech Hunter